Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor

被引：0
|
作者：
Ying Lin
Bo Yu
Haifeng Sun
Hongyu Zhang
Zhihuang Hu
Yao Zhang
Zhenhua Wu
Si Sun
Xinmin Zhao
Hui Yu
Xianghua Wu
Yuan Li
Jialei Wang
Huijie Wang
机构：
[1] Fudan University Shanghai Cancer Center,Department of Thoracic Medical Oncology
[2] Shanghai Medical College,Department of Oncology
[3] Fudan University,Third Department of Medical Oncology
[4] Shaanxi Provincial Cancer Hospital Affiliated to Medical College of Xi’an Jiaotong University,Department of Thoracic Surgery
[5] Zhongshan Hospital,Department of Pathology
[6] Fudan University,undefined
[7] Fudan University Shanghai Cancer Center,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Thoracic SMARCA4-deficient undifferentiated tumor; SMARCA4-deficient thoracic sarcomatoid tumor; SMARCA4-deficient thoracic sarcoma; Immune checkpoint inhibitor; LRP1B;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：8663 / 8671
页数：8
相关论文
共 50 条
  • [21] Thoracic SMARCA4-deficient undifferentiated tumor: A rare entity and challenging diagnosis
    Sami, F., I
    Lack, M.
    Hamza, A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S106 - S106
  • [22] THORACIC SMARCA4-DEFICIENT UNDIFFERENTIATED TUMOR: A CASE REPORT WITH MOLECULAR ANALYSIS
    Parmar, Miloni
    Jagadeesan, Cindrel Tharumia
    Popuri, Niveditha
    Sawh, Ravindranauth
    Zhao, Lichao
    Youness, Houssein
    Keddissi, Jean I.
    CHEST, 2024, 166 (04) : 4189A - 4190A
  • [23] Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor
    Zhou, Ping
    Fu, Yiyun
    Tang, Yuan
    Jiang, Lili
    Wang, Weiya
    PEERJ, 2024, 12
  • [24] Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy
    Zhou, Ping
    Fu, Yiyun
    Tang, Yuan
    Jiang, Lili
    Wang, Weiya
    LUNG CANCER, 2024, 189
  • [25] Iodine-125 Seed Implantation and Transarterial Chemoinfusion Combined with Immune Checkpoint Inhibitors for a Thoracic SMARCA4-Deficient Undifferentiated Tumor
    Li, Bin
    Li, Xiao-Guang
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2023, 34 (01) : 147 - 149
  • [26] SMARCA4-deficient undifferentiated tumor: A case report
    Martinez, Marta Segado
    Garcia, Gema Ruiz
    MEDICINA CLINICA, 2022, 159 (09): : E59 - E60
  • [27] Anlotinib Combined with Immune Checkpoint Inhibitor May Benifit Advanced Smarca4-Deficient Thoracic Tumor Patients in First Line
    Lou, Y.
    Li, R.
    Liu, B.
    Li, Y.
    Wang, D.
    Zhang, W.
    Han, B.
    Qian, F.
    Zhang, Y.
    Zhang, B.
    Zhang, L.
    Ma, W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S613 - S613
  • [28] Efficacy of immune checkpoint inhibitors in SMARCA4-deficient and TP53 mutant undifferentiated lung cancer
    Chen, Jianxin
    Zheng, Qinhong
    Wang, Junhui
    Zhang, Xueli
    Lv, Yingguo
    MEDICINE, 2024, 103 (08) : E36959
  • [29] AN AGGRESSIVE CASE OF THORACIC UNDIFFERENTIATED SMARCA4-DEFICIENT TUMOR WITH EXTENSIVE PLEURAL INVOLVEMENT
    Boshara, Peter
    Hanona, Paul
    Poudel, Shyam
    Jaiyesimi, Ishmael
    Ezekwudo, Daniel
    Allen, Timothy
    Nair, Girish
    CHEST, 2023, 164 (04) : 4286A - 4287A
  • [30] Thoracic SMARCA4-deficient undifferentiated tumor with associated granulomatous reaction and response to pembrolizumab
    Marshall, Mason
    Khader, Samer
    Beasley, Scott
    Lajara, Sigfred
    DIAGNOSTIC CYTOPATHOLOGY, 2023, 51 (10) : E287 - E293
12345